XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -76.31%1.09B | -76.31%1.09B | -65.08%1.22B | -51.28%792M | -77.40%838M | 77.23%4.58B | 77.23%4.58B | 23.62%3.5B | -13.19%1.63B | 58.76%3.71B |
-Cash and cash equivalents | -76.31%1.09B | -76.31%1.09B | -65.08%1.22B | -51.28%792M | -77.40%838M | 77.23%4.58B | 77.23%4.58B | 23.62%3.5B | -13.19%1.63B | 58.76%3.71B |
Receivables | -4.22%2.38B | -4.22%2.38B | 9.47%2.46B | 9.59%2.4B | 7.83%2.24B | 17.64%2.49B | 17.64%2.49B | 18.90%2.25B | 19.43%2.19B | 23.98%2.08B |
-Accounts receivable | -4.22%2.38B | -4.22%2.38B | 9.47%2.46B | 9.59%2.4B | 7.83%2.24B | 17.64%2.49B | 17.64%2.49B | 18.90%2.25B | 19.43%2.19B | 23.98%2.08B |
Inventory | ---- | ---- | 13.45%54M | -12.21%46M | -10.68%46M | 1.54%52.8M | 1.54%52.8M | 9.68%47.6M | 21.02%52.4M | 3.83%51.5M |
Other current assets | 30.56%1.13B | 30.56%1.13B | 11.14%1.18B | -10.32%963M | -2.97%935M | 28.65%866.3M | 28.65%866.3M | 8.15%1.06B | -7.97%1.07B | 61.41%963.6M |
Total current assets | -42.41%4.6B | -42.41%4.6B | -28.29%4.91B | -14.97%4.21B | -40.33%4.06B | 47.24%7.99B | 47.24%7.99B | 19.32%6.85B | 0.53%4.95B | 46.01%6.8B |
Non current assets | ||||||||||
Net PPE | 0.55%38.63B | 0.55%38.63B | 8.94%39.41B | 3.89%38.05B | 4.28%37.96B | 5.73%38.42B | 5.73%38.42B | 3.68%36.17B | 1.36%36.62B | -3.73%36.4B |
-Gross PPE | -32.32%38.63B | -32.32%38.63B | 8.47%58.81B | 4.45%57.08B | 4.96%56.71B | 6.49%57.08B | 6.49%57.08B | 5.71%54.22B | 3.29%54.65B | -2.03%54.03B |
-Accumulated depreciation | ---- | ---- | -7.54%-19.4B | -5.58%-19.04B | -6.36%-18.75B | -8.10%-18.66B | -8.10%-18.66B | -10.03%-18.04B | -7.45%-18.03B | -1.67%-17.63B |
Goodwill and other intangible assets | ---- | ---- | 8.59%3.22B | 2.67%3.05B | 3.32%3.03B | 4.83%3.04B | 4.83%3.04B | 11.84%2.97B | 9.04%2.97B | 4.15%2.93B |
-Goodwill | ---- | ---- | 8.59%3.22B | 2.67%3.05B | 3.32%3.03B | 4.83%3.04B | 4.83%3.04B | 11.84%2.97B | 9.04%2.97B | 4.15%2.93B |
Investments and advances | ---- | ---- | 185.19%2.96B | 176.86%2.88B | 165.08%2.88B | 1.47%1.08B | 1.47%1.08B | 7.69%1.04B | -3.28%1.04B | -7.61%1.09B |
Other non current assets | 112.72%11.95B | 112.72%11.95B | 12.06%5.67B | 15.57%5.63B | 16.50%5.59B | 19.34%5.62B | 19.34%5.62B | 18.99%5.06B | 10.57%4.87B | 8.56%4.79B |
Total non current assets | 5.03%50.58B | 5.03%50.58B | 13.31%51.26B | 9.01%49.6B | 9.38%49.46B | 7.00%48.16B | 7.00%48.16B | 5.80%45.24B | 2.64%45.5B | -2.18%45.22B |
Total assets | -1.72%55.18B | -1.72%55.18B | 7.84%56.17B | 6.66%53.8B | 2.88%53.51B | 11.32%56.15B | 11.32%56.15B | 7.40%52.09B | 2.42%50.44B | 2.23%52.01B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | 98.67%3.26B | 17.75%1.69B | 11.03%2.09B | 37.47%2.08B | 37.47%2.08B | 18.43%1.64B | -1.51%1.44B | 18.81%1.88B |
-accounts payable | ---- | ---- | 9.46%944M | 17.65%949M | 15.30%936M | 12.52%1.1B | 12.52%1.1B | 8.51%862.4M | 9.09%806.6M | 12.97%811.8M |
-Total tax payable | ---- | ---- | 34.92%1.05B | 17.86%743M | 7.78%1.15B | 83.60%973.1M | 83.60%973.1M | 31.80%777.5M | -12.41%630.4M | 23.68%1.07B |
-Dividends payable | ---- | ---- | --1.27B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Current accrued expenses | ---- | ---- | 5.39%1.79B | 0.87%1.56B | -2.78%1.51B | 16.66%1.9B | 16.66%1.9B | 17.16%1.69B | 16.38%1.55B | -20.85%1.55B |
Current debt and capital lease obligation | ---- | ---- | 89.19%1.26B | -4.69%655M | 8.06%1.29B | 335.71%2.88B | 335.71%2.88B | 2.02%668.1M | -0.35%687.2M | 72.41%1.19B |
-Current debt | ---- | ---- | --596M | ---- | 15.22%604M | --2.19B | --2.19B | ---- | ---- | --524.2M |
-Current capital lease obligation | ---- | ---- | -0.01%668M | -4.69%655M | 2.44%685M | 4.08%688.1M | 4.08%688.1M | 2.02%668.1M | -0.35%687.2M | -3.35%668.7M |
Other current liabilities | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- |
Current liabilities | -43.71%3.86B | -43.71%3.86B | 57.59%6.31B | 6.43%3.91B | 5.65%4.89B | 80.40%6.86B | 80.40%6.86B | 14.82%4B | 5.56%3.67B | 9.21%4.62B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 2.19%51.31B | 2.19%51.31B | 6.25%52.15B | 7.45%51.34B | 1.78%49.59B | 4.52%50.21B | 4.52%50.21B | 5.25%49.08B | 1.89%47.78B | 3.98%48.73B |
-Long term debt | 3.42%38.42B | 3.42%38.42B | 4.60%38.99B | 7.88%38.52B | 0.44%36.76B | 3.48%37.15B | 3.48%37.15B | 6.91%37.27B | 3.28%35.71B | 7.69%36.6B |
-Long term capital lease obligation | -1.30%12.89B | -1.30%12.89B | 11.43%13.16B | 6.18%12.82B | 5.82%12.83B | 7.61%13.06B | 7.61%13.06B | 0.34%11.81B | -1.99%12.07B | -5.82%12.12B |
Non current deferred liabilities | -22.54%1.91B | -22.54%1.91B | -17.56%1.97B | 0.52%2.4B | -2.38%2.58B | -10.32%2.47B | -10.32%2.47B | -16.99%2.38B | -19.92%2.39B | -5.32%2.64B |
Other non current liabilities | 99.22%1.89B | 99.22%1.89B | -13.23%854M | -15.05%885M | -12.50%927M | -9.71%949.7M | -9.71%949.7M | -0.67%984.2M | 1.86%1.04B | -2.99%1.06B |
Total non current liabilities | 2.08%55.12B | 2.08%55.12B | 3.97%55.04B | 5.69%54.72B | 0.55%53.46B | 2.58%53.99B | 2.58%53.99B | 2.64%52.94B | -0.71%51.77B | 1.01%53.17B |
Total liabilities | -3.08%58.98B | -3.08%58.98B | 7.74%61.35B | 5.74%58.63B | 0.96%58.35B | 7.82%60.85B | 7.82%60.85B | 3.41%56.94B | -0.32%55.44B | 1.62%57.79B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | 2.41%17M | 2.41%17M | 2.41%17M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M |
-common stock | ---- | ---- | 2.41%17M | 2.41%17M | 2.41%17M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M | 0.00%16.6M |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | ---- | ---- | 3.46%64.82B | 5.84%65.03B | 6.59%64.2B | 6.61%63.48B | 6.61%63.48B | 6.63%62.65B | 6.32%61.44B | 4.55%60.24B |
Paid-in capital | ---- | ---- | 4.19%9.19B | 3.65%9.06B | 4.23%9B | 4.05%8.89B | 4.05%8.89B | 4.31%8.82B | 4.26%8.74B | 3.95%8.64B |
Less: Treasury stock | ---- | ---- | 4.16%76.87B | 5.12%76.46B | 4.64%75.52B | 4.21%74.64B | 4.21%74.64B | 3.60%73.8B | 3.45%72.73B | 4.17%72.17B |
Gains losses not affecting retained earnings | ---- | ---- | 8.20%-2.34B | -0.30%-2.46B | -1.75%-2.53B | 1.23%-2.46B | 1.23%-2.46B | 0.55%-2.55B | -9.31%-2.46B | 5.77%-2.49B |
Total stockholders'equity | 19.33%-3.8B | 19.33%-3.8B | -6.64%-5.18B | 3.50%-4.82B | 16.34%-4.83B | 21.60%-4.71B | 21.60%-4.71B | 26.06%-4.85B | 21.52%-5B | 3.58%-5.78B |
Total equity | 19.33%-3.8B | 19.33%-3.8B | -6.64%-5.18B | 3.50%-4.82B | 16.33%-4.83B | 21.60%-4.71B | 21.60%-4.71B | 26.06%-4.85B | 21.52%-5B | 3.58%-5.78B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |